You are here

Amgen

Amgen’s Imdelltra BiTEs into SCLC treatment drought

Clinical Trials Arena

Sun, 07/14/24 - 10:15 pm

small cell lung cancer

Amgen Axes Development of Early-Stage Bispecific T-Cell Engager for Solid Tumors

BioSpace

Wed, 07/10/24 - 11:11 am

clinical trials

In boost to Amgen, analysts predict osteoporosis market share shift

Fierce Pharma

Fri, 06/28/24 - 11:28 am

Amgen’s Blincyto approved by FDA for new acute lymphoblastic leukaemia indication

PM Live

Mon, 06/17/24 - 10:28 pm

acute lymphoblastic leukemia

Amgen's drug meets main goal in late-stage study for rare disease

Reuters

Wed, 06/5/24 - 11:03 am

clinical trials

ASCO: Bristol Myers' KRAS confirmatory data avoid Amgen's flaws but leave FDA prospect unclear

Fierce Pharma

Sun, 06/2/24 - 02:51 pm

Bristol Myers Squibb

KRAS inhibitors

non-small cell lung cancer

FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment

Reuters

Tue, 05/28/24 - 10:29 pm

Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD

Fierce Pharma

Mon, 05/20/24 - 11:25 am

In Big Pharma's growth rankings, Lilly took top spot from Novo Nordisk in Q1

Fierce Pharma

Thu, 05/16/24 - 09:51 pm

FDA approves Amgen drug for small cell lung cancer

Reuters

Thu, 05/16/24 - 09:47 pm

small cell lung cancer

Winners and Losers in Biopharma’s Q1 2024 Earnings Season

BioSpace

Wed, 05/15/24 - 11:30 am

Bristol Myers Squibb

Big Pharma’s most improved drugs: a new generation of blockbusters

Pharma Voice

Tue, 05/14/24 - 11:34 am

Amgen's new Horizon products bolster top line despite continued Tepezza struggles

Fierce Pharma

Fri, 05/3/24 - 11:23 am

Amgen 'encouraged' by weight-loss drug interim data, shares jump

Reuters

Thu, 05/2/24 - 10:19 pm

clinical trials

Amgen’s profit slides, revenue jumps in Q1

Medical Marketing and Media

Thu, 05/2/24 - 10:09 pm

Amgen Highlights New COPD, Asthma and Vasculitis Research at ATS 2024

BioSpace

Wed, 05/1/24 - 09:31 am

Amgen CEO nabs pay raise thanks to Horizon deal. Does that incentivize aggressive M&A?

Fierce Pharma

Thu, 04/18/24 - 10:21 pm

executive compensation

Amgen, facing potential Enbrel price cap in Colorado, takes state's new drug affordability board to court

Fierce Pharma

Tue, 03/26/24 - 04:31 pm

Acelyrin adds proof-of-concept TED data to recent readout pile, cementing challenge to Amgen

Fierce Biotech

Wed, 03/20/24 - 11:50 am

thyroid eye disease

clinical trials

Sandoz Nabs FDA Approvals for First Two Biosimilars for Amgen’s Denosumab

BioSpace

Wed, 03/6/24 - 11:29 am

Pages